The European flexible endoscopes market, mainly driven by favorable reimbursements in select geographies, growing aging population, and the increasing prevalence/incidence of diseases requiring endoscopy procedures, was valued at $1.27 billion in 2013, and is expected to reach $1.91 billion by 2018, at a CAGR of 8.5%, during the forecast period, 2013 to 2018.
The report analyzes the market of devices by segments such as colonoscope, bronchoscope, upper GI endoscope, laryngoscope, pharyngoscope, deudonoscope, naso-pharyngoscope, and rhinoscope, among others. With a market value of $0.78 billion and $0.63 billion respectively, the colonoscope and upper GI endoscope segments have been contributing 25.2% and 20.3% to the total European flexible endoscopes market. All these segments experienced a positive growth owing to an increased awareness of patients and physicians towards the usage and reception of new endoscopy technologies, due to the numerous advantages offered by flexible endoscopes devices.
The demand for flexible endoscopes has increased significantly, largely because of patients’ preference for minimally invasive surgeries. Endoscopic procedures are low-risk procedures and are easily covered by health insurance. A pivotal factor that propels the growth of the endoscopy market is the rapid rise in the number of elderly people who are prone to orthopedic, gastrointestinal, and ophthalmic diseases, as well as cancer. As per the World Health Organization (WHO), between 2000 and 2050, the proportion of the world's population that is aged 60 years will double from about 11% to 22%. This aging population is the main end-user of knee-hip implants, bariatric surgeries, gastrointestinal endoscopy, and colonoscopy procedures. With the growing number of elderly people, age-related ailments are also expected to rise sharply, thus propelling the demand and consumption of flexible endoscopes devices concomitantly.
The rapidly aging population, increased obesity rates, growing incidence of associated disease are some of the major factors driving the European Flexible Endoscopes market. Europe accounts for the second-highest share of the global market, followed by Asia, and Rest of the World (RoW). Many European countries such as the U.K., Germany, and France are witnessing a rise in the number of endoscopic surgeries performed. From 2011 to 2012, more than 360,000 colonoscopies and over 217000 flexible sigmoidoscopies were performed in the U.K. alone. Furthermore, the department of health in the U.K. has predicted a 10% to 20% year-on-year increase in the demand for endoscopies. Bowel scope screening is expected to have a positive impact on the endoscopy market in the U.K.
The report also provides an extensive competitive landscaping of the leading companies operating in the flexible endoscopes market. The key players in flexible endoscopes segment are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. The segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Customization Options:
Along with the market data, customize the MMM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a deep dive analysis of the following parameters:
Product Analysis:
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix, which gives a detailed comparison of Flexible Endoscopes product portfolio of each company, mapped at country and sub-segment levels
- End-user adoption rate analysis of products (segment-wise and country-wise)
- A comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data:
- Country-specific prevalence of cancer, gastrointestinal tract disorders, gastroesophageal reflux disorder (GERD), and gynecological disorders
- Country-specific patient pool of cancer, gastrointestinal tract disorders, gastroesophageal reflux disorder (GERD), and gynecological disorders
- Disease progression (pattern analysis)
Procedure Volume Data:
- Different types of flexible endoscopes procedures performed annually in each country, tracked till sub- segment level
- The number of abdominal, gastro intestinal, interior of joints, gynecology, bronchology, and large & small intestinal procedures performed in each country
Surgeons/Physicians Perception Matrix:
- Fast turn-around analysis of surgeons’ responses to market events and trends
- Surgeons’ opinions about products from different companies
- Surgeons’ qualitative inputs on epidemiology date
Pricing Trends:
- Cost analysis of flexible endoscopes devices in the region
- Abdominal, gastro intestinal, interior of joints, gynecology, bronchology, large & small intestinal procedural investment in major countries
Competitive Intelligence
- The company share analysis of the top players of the market in the region
- The crucial developments and strategies that companies inculcate in their portfolio
Perception Matrix:
- A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- An analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant: It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters such patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and cancer centers, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE | PUBLISHED | |
---|---|---|
North American Endoscopes Market The North American endoscope market was valued at $4.9 billion in 2013 and is expected to reach $6.8 billion by 2018, growing at a CAGR of 6.8% during the forecast period. The key players in this market are Stryker Corporation, Ethicon Endo-Surgery, Inc., Olympus Corporation, Covidien plc, Arthrex, Inc., Smiths Group plc, Aesculap, Inc., ConMed Corporation, Richard Wolf GmbH, Hoya Corporation, and Fujifilm Holdings Corporation. The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report. |
Upcoming | |
European Endoscopes Market The European endoscope market was valued at $3.2 billion in 2013 and is expected to reach $4.2 billion by 2018, growing at a CAGR of 5.7% during the forecast period. The key players in this market are Stryker Corporation, Ethicon Endo-Surgery, Inc., Olympus Corporation, Covidien plc, Arthrex, Inc., Smiths Group plc, Aesculap, Inc., ConMed Corporation, Richard Wolf GmbH, Hoya Corporation, and Fujifilm Holdings Corporation. The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report. |
Upcoming | |
Asian Endoscopes Market The Asian endoscope market was valued at $2.9 billion in 2013 and is expected to reach $4.2 billion by 2018, growing at a CAGR of 7.6% during the forecast period. The key players in this market are Stryker Corporation, Ethicon Endo-Surgery, Inc., Olympus Corporation, Covidien plc, Arthrex, Inc., Smiths Group plc, Aesculap, Inc., ConMed Corporation, Richard Wolf GmbH, Hoya Corporation, and Fujifilm Holdings Corporation. The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report. |
Upcoming |